NOVARTIS PHARMA AG - 15 Jun 2022 Form 3 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: 10%+ Owner
Signature: Novartis Pharma AG /s/ Christian Rehm, Authorized Signatory /s/ Lukas Foertsch, Authorized Signatory
Issuer symbol: DTIL
Transactions as of: 15 Jun 2022
Net transactions value: $0
Form type: 3
Filing time: 27 Jun 2022, 16:38:39 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DTIL	Common Stock						12,407,440	15 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Novartis Pharma AG is the record holder of the securities reported herein. As the parent of Novartis Pharma AG, Novartis AG is the beneficial ownership of these securities.